Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 187

1.

89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.

Holland JP, Divilov V, Bander NH, Smith-Jones PM, Larson SM, Lewis JS.

J Nucl Med. 2010 Aug;51(8):1293-300. doi: 10.2967/jnumed.110.076174. Epub 2010 Jul 21.

PMID:
20660376
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Targeting the internal epitope of prostate-specific membrane antigen with 89Zr-7E11 immuno-PET.

Ruggiero A, Holland JP, Hudolin T, Shenker L, Koulova A, Bander NH, Lewis JS, Grimm J.

J Nucl Med. 2011 Oct;52(10):1608-15. doi: 10.2967/jnumed.111.092098. Epub 2011 Sep 9.

PMID:
21908391
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab.

Holland JP, Caldas-Lopes E, Divilov V, Longo VA, Taldone T, Zatorska D, Chiosis G, Lewis JS.

PLoS One. 2010 Jan 25;5(1):e8859. doi: 10.1371/journal.pone.0008859.

PMID:
20111600
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.

Smith-Jones PM, Vallabhajosula S, Navarro V, Bastidas D, Goldsmith SJ, Bander NH.

J Nucl Med. 2003 Apr;44(4):610-7.

PMID:
12679407
[PubMed - indexed for MEDLINE]
Free Article
5.

Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas.

Bhattacharyya S, Kurdziel K, Wei L, Riffle L, Kaur G, Hill GC, Jacobs PM, Tatum JL, Doroshow JH, Kalen JD.

Nucl Med Biol. 2013 May;40(4):451-7. doi: 10.1016/j.nucmedbio.2013.01.007. Epub 2013 Feb 27.

PMID:
23454247
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Cerenkov luminescence imaging of medical isotopes.

Ruggiero A, Holland JP, Lewis JS, Grimm J.

J Nucl Med. 2010 Jul;51(7):1123-30. doi: 10.2967/jnumed.110.076521. Epub 2010 Jun 16.

PMID:
20554722
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Quantitative immunoPET of prostate cancer xenografts with 89Zr- and 124I-labeled anti-PSCA A11 minibody.

Knowles SM, Zettlitz KA, Tavaré R, Rochefort MM, Salazar FB, Stout DB, Yazaki PJ, Reiter RE, Wu AM.

J Nucl Med. 2014 Mar;55(3):452-9. doi: 10.2967/jnumed.113.120873. Epub 2014 Feb 6.

PMID:
24504052
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen.

Smith-Jones PM, Vallabahajosula S, Goldsmith SJ, Navarro V, Hunter CJ, Bastidas D, Bander NH.

Cancer Res. 2000 Sep 15;60(18):5237-43.

PMID:
11016653
[PubMed - indexed for MEDLINE]
Free Article
9.

89Zr-Desferrioxamine B-J591 anti-prostate-specific membrane antigen monoclonal antibody.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 Sep 12 [updated 2010 Nov 18].

10.

Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.

Verel I, Visser GW, Boellaard R, Boerman OC, van Eerd J, Snow GB, Lammertsma AA, van Dongen GA.

J Nucl Med. 2003 Oct;44(10):1663-70.

PMID:
14530484
[PubMed - indexed for MEDLINE]
Free Article
11.

89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.

Verel I, Visser GW, Boellaard R, Stigter-van Walsum M, Snow GB, van Dongen GA.

J Nucl Med. 2003 Aug;44(8):1271-81.

PMID:
12902418
[PubMed - indexed for MEDLINE]
Free Article
12.

PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.

Elsässer-Beile U, Reischl G, Wiehr S, Bühler P, Wolf P, Alt K, Shively J, Judenhofer MS, Machulla HJ, Pichler BJ.

J Nucl Med. 2009 Apr;50(4):606-11. doi: 10.2967/jnumed.108.058487. Epub 2009 Mar 16. Erratum in: J Nucl Med. 2009 Jun;50(6):958.

PMID:
19289418
[PubMed - indexed for MEDLINE]
Free Article
13.

Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30.

Perk LR, Stigter-van Walsum M, Visser GW, Kloet RW, Vosjan MJ, Leemans CR, Giaccone G, Albano R, Comoglio PM, van Dongen GA.

Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1857-67. doi: 10.1007/s00259-008-0774-5. Epub 2008 May 20.

PMID:
18491091
[PubMed - indexed for MEDLINE]
14.

ImmunoPET imaging of renal cell carcinoma with (124)I- and (89)Zr-labeled anti-CAIX monoclonal antibody cG250 in mice.

Stillebroer AB, Franssen GM, Mulders PF, Oyen WJ, van Dongen GA, Laverman P, Oosterwijk E, Boerman OC.

Cancer Biother Radiopharm. 2013 Sep;28(7):510-5. doi: 10.1089/cbr.2013.1487. Epub 2013 May 22.

PMID:
23697926
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging.

Dijkers EC, Kosterink JG, Rademaker AP, Perk LR, van Dongen GA, Bart J, de Jong JR, de Vries EG, Lub-de Hooge MN.

J Nucl Med. 2009 Jun;50(6):974-81. doi: 10.2967/jnumed.108.060392. Epub 2009 May 14.

PMID:
19443585
[PubMed - indexed for MEDLINE]
Free Article
16.

Development of a novel long-lived immunoPET tracer for monitoring lymphoma therapy in a humanized transgenic mouse model.

Natarajan A, Habte F, Gambhir SS.

Bioconjug Chem. 2012 Jun 20;23(6):1221-9. doi: 10.1021/bc300039r. Epub 2012 Jun 11.

PMID:
22621257
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET.

Tinianow JN, Gill HS, Ogasawara A, Flores JE, Vanderbilt AN, Luis E, Vandlen R, Darwish M, Junutula JR, Williams SP, Marik J.

Nucl Med Biol. 2010 Apr;37(3):289-97. doi: 10.1016/j.nucmedbio.2009.11.010. Epub 2010 Feb 10.

PMID:
20346868
[PubMed - indexed for MEDLINE]
18.

In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen.

Li Y, Tian Z, Rizvi SM, Bander NH, Allen BJ.

Prostate Cancer Prostatic Dis. 2002;5(1):36-46.

PMID:
15195129
[PubMed - indexed for MEDLINE]
Free Article
19.

Pharmacokinetics, biodistribution, and gamma camera imaging of 111In-KC-4G3 murine monoclonal antibody in athymic nude mice with or without human tumor xenografts.

Longley C, Furmanski P, Dienhart DG, Lear J, Bloedow D, Kasliwal R, Bunn PA Jr.

Cancer Res. 1990 Sep 15;50(18):5954-61.

PMID:
2393864
[PubMed - indexed for MEDLINE]
Free Article
20.

In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice.

Schneider DW, Heitner T, Alicke B, Light DR, McLean K, Satozawa N, Parry G, Yoo J, Lewis JS, Parry R.

J Nucl Med. 2009 Mar;50(3):435-43. doi: 10.2967/jnumed.108.055608. Epub 2009 Feb 17.

PMID:
19223400
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk